Chrna4 A529 knock-in mice exhibit altered nicotine sensitivity

Pharmacogenetics and Genomics

Volumn 20, Issue 2, 2010, Pages 121-130

  Wilking, Jennifer A ^a,c   Hesterberg, Kirstin G ^a   Crouch, Eric L ^a   Homanics, Gregg E ^b   Stitzel, Jerry A ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Addiction; Conditioned place preference; Genetics; Nicotinic receptor; Oral consumption; Polymorphism

Indexed keywords

ACETYLCHOLINE; ALANINE; NICOTINIC RECEPTOR ALPHA4; THREONINE;

ALPHA CHAIN; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CODON; CONTROLLED STUDY; DNA POLYMORPHISM; EFFUSION; FEMALE; GENE; GENE IDENTIFICATION; GENE MUTATION; GENETIC CODE; GENETIC VARIABILITY; HYPOTHERMIA; MALE; MESENCEPHALON; MOUSE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; TASK PERFORMANCE; TOBACCO DEPENDENCE;

ACETYLCHOLINE; ADMINISTRATION, ORAL; ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; GENE KNOCK-IN TECHNIQUES; MICE; MUTATION; NICOTINE; ORGAN SPECIFICITY; POLYMORPHISM, SINGLE NUCLEOTIDE; PYRIDINES; RECEPTORS, NICOTINIC; REPRODUCIBILITY OF RESULTS;

MUS;

EID: 75649116998     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e3283369347     Document Type: Article

References (53)

1. Center for Disease Control. State-specific prevalence and trends in adult cigarette smoking-United States, 1998-2007. MMWR Morb Mortal Wkly Rep. 2009; 58: 221-226.
2. Fisher RA. Cancer and smoking. Nature 1958; 182:596.
3. Fisher RA. Lung cancer and cigarettes. Nature 1958; 182:108.
4. Li MD. The genetics of nicotine dependence. Curr Psychiatry Rep 2006; 8:158-164.
5. Stitzel JA, Leonard SS, Collins AC. Genetic regulation of nicotine-related behaviors and brain nicotinic receptors. In: Clemente F, Gotti C, Fornasari D, editors. Handbook of experimental pharmacology: neuronal nicotinic receptors. Milan, Italy: Springer-Verlag; 2000. pp. 563-585.
6. Marks MJ, Stitzel JA, Collins AC. Genetic influences on nicotine responses. Pharmacol Biochem Behav 1989; 33:667-678.
7. Miner LL, Collins AC. Strain comparison of nicotine-induced seizure sensitivity and nicotinic receptors. Pharmacol Biochem Behav 1989; 33: 469-475.
8. Marks MJ, Campbell SM, Romm E, Collins AC. Genotype influences the development of tolerance to nicotine in the mouse. J Pharmacol Exp Ther 1991; 259:392-402.
9. Marks MJ, Romm E, Gaffney DK, Collins AC. Nicotine-induced tolerance and receptor changes in four mouse strains. J Pharmacol Exp Ther 1986; 237:809-819.
10. Marks MJ, Stitzel JA, Collins AC. Dose-response analysis of nicotine tolerance and receptor changes in two inbred mouse strains. J Pharmacol Exp Ther 1986; 239:358-364.
11. Robinson SF, Marks MJ, Collins AC. Inbred mouse strains vary in oral self-selection of nicotine. Psychopharmacology (Berl) 1996; 124: 332-339.
12. Butt CM, King NM, Hutton SR, Collins AC, Stitzel JA. Modulation of nicotine but not ethanol preference by the mouse Chrna4 A529T polymorphism. Behav Neurosci 2005; 119:26-37.
13. Li XC, Karadsheh MS, Jenkins PM, Stitzel JA. Genetic correlation between the free-choice oral consumption of nicotine and alcohol in C57BL/6JxC3H/ HeJ F2 intercross mice. Behav Brain Res 2005; 157:79-90.
14. Schechter MD, Meehan SM, Schechter JB. Genetic selection for nicotine activity in mice correlates with conditioned place preference. Eur J Pharmacol 1995; 279:59-64.
15. Grabus SD, Martin BR, Brown SE, Damaj MI. Nicotine place preference in the mouse: influences of prior handling, dose and strain and attenuation by nicotinic receptor antagonists. Psychopharmacology (Berl) 2006; 184:456-463.
16. Risinger FO, Brown MM. Genetic differences in nicotine-induced conditioned taste aversion. Life Sci 1996; 58:223-229.
17. Portugal GS, Gould TJ. Genetic variability in nicotinic acetylcholine receptors and nicotine addiction: converging evidence from human and animal research. Behav Brain Res 2008; 193:1-16.
18. Li MD. Identifying susceptibility loci for nicotine dependence: 2008 update based on recent genome-wide linkage analyses. Hum Genet 2008; 123:119-131.
19. Stitzel JA, Jimenez M, Marks MJ, Tritto T, Collins AC. Potential role of the alpha4 and alpha6 nicotinic receptor subunits in regulating nicotine-induced seizures. J Pharmacol Exp Ther 2000; 293:67-74.
20. Tritto T, Stitzel JA, Marks MJ, Romm E, Collins AC. Variability in response to nicotine in the LSxSS RI strains: potential role of polymorphisms in alpha4 and alpha6 nicotinic receptor genes. Pharmacogenetics 2002; 12:197-208.
21. Tritto T, Marley RJ, Bastidas D, Stitzel JA, Collins AC. Potential regulation of nicotine and ethanol actions by alpha4-containing nicotinic receptors. Alcohol 2001; 24:69-78.
22. Lukas RJ, Changeux JP, Le Novere N, Albuquerque EX, Balfour DJ, Berg DK, et al. International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. Pharmacol Rev 1999; 51:397-401.
23. Flores CM, Rogers SW, Pabreza LA, Wolfe BB, Kellar KJ. A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment. Mol Pharmacol 1992; 41:31-37.
24. Whiting P, Lindstrom J. Purification and characterization of a nicotinic acetylcholine receptor from rat brain. Proc Natl Acad Sci USA 1987; 84:595-599.
25. Corrigall WA, Coen KM, Adamson KL. Self-administered nicotine activates the mesolimbic dopamine system through the ventral segmental area. Brain Res 1994; 653:278-284.
26. Epping-Jordan MP, Picciotto MR, Changeux JP, Pich EM. Assessment of nicotinic acetylcholine receptor subunit contributions to nicotine self-administration in mutant mice. Psychopharmacology (Berl) 1999; 147:25-26.
27. Tapper AR, McKinney SL, Nashmi R, Schwarz J, Deshpande P, Labarca C, et al. Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization. Science 2004; 306:1029-1032.
28. Walters CL, Brown S, Changeux JP, Martin B, Damaj MI. The beta2 but not alpha7 subunit of the nicotinic acetylcholine receptor is required for nicotine-conditioned place preference in mice. Psychopharmacology (Berl) 2006; 184:339-344.
29. Kim H, Flanagin BA, Qin C, Macdonald RL, Stitzel JA. The mouse Chrna4 A529T polymorphism alters the ratio of high to low affinity alpha 4 beta 2 nAChRs. Neuropharmacology 2003; 45:345-354.
30. Butt CM, Hutton SR, Stitzel JA, Balogh SA, Owens JC, Collins AC. A polymorphism in the alpha4 nicotinic receptor gene (Chrna4) modulates enhancement of nicotinic receptor function by ethanol. Alcohol Clin Exp Res 2003; 27:733-742.
31. Dobelis P, Marks MJ, Whiteaker P, Balogh SA, Collins AC, Stitzel JA. A polymorphism in the mouse neuronal alpha4 nicotinic receptor subunit results in an alteration in receptor function. Mol Pharmacol 2002; 62:334-342.
32. Labarca C, Schwarz J, Deshpande P, Schwarz S, Nowak MW, Fonck C, et al. Point mutant mice with hypersensitive alpha 4 nicotinic receptors show dopaminergic deficits and increased anxiety. Proc Natl Acad Sci USA 2001; 98:2786-2791.
33. Marks MJ, Whiteaker P, Calcaterra J, Stitzel JA, Bullock AE, Grady SR, et al. Two pharmacologically distinct components of nicotinic receptor-mediated rubidium efflux in mouse brain require the beta2 subunit. J Pharmacol Exp Ther 1999; 289:1090-1103.
34. Whiteaker P, Jimenez M, McIntosh JM, Collins AC, Marks MJ. Identification of a novel nicotinic binding site in mouse brain using [(125)I]-epibatidine. Br J Pharmacol 2000; 131:729-739.
35. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193:265-275.
36. Zwart R, Vijverberg HP. Four pharmacologically distinct subtypes of alpha4beta2 nicotinic acetylcholine receptor expressed in Xenopus laevis oocytes. Mol Pharmacol 1998; 54:1124-1131.
37. Covernton PJ, Connolly JG. Multiple components in the agonist concentration-response relationships of neuronal nicotinic acetylcholine receptors. J Neurosci Methods 2000; 96:63-70.
38. Buisson B, Bertrand D. Chronic exposure to nicotine upregulates the human (alpha)4(beta)2 nicotinic acetylcholine receptor function. J Neurosci 2001; 21:1819-1829.
39. Nelson ME, Kuryatov A, Choi CH, Zhou Y, Lindstrom J. Alternate stoichiometries of alpha4beta2 nicotinic acetylcholine receptors. Mol Pharmacol 2003; 63:332-341.
40. McCallum SE, Collins AC, Paylor R, Marks MJ. Deletion of the beta 2 nicotinic acetylcholine receptor subunit alters development of tolerance to nicotine and eliminates receptor upregulation. Psychopharmacology (Berl) 2006; 184:314-327.
41. Tapper AR, McKinney SL, Marks MJ, Lester HA. Nicotine responses in hypersensitive and knockout alpha 4 mice account for tolerance to both hypothermia and locomotor suppression in wild-type mice. Physiol Genomics 2007; 31:422-428.
42. Salas R, Cook KD, Bassetto L, De Biasi M. The alpha3 and beta4 nicotinic acetylcholine receptor subunits are necessary for nicotine-induced seizures and hypolocomotion in mice. Neuropharmacology 2004; 47:401-407.
43. Drenan RM, Grady SR, Whiteaker P, McClure-Begley T, McKinney S, Miwa JM, et al. In vivo activation of midbrain dopamine neurons via sensitized, high-affinity alpha 6 nicotinic acetylcholine receptors. Neuron 2008; 60:123-136.
44. Maskos U, Molles BE, Pons S, Besson M, Guiard BP, Guilloux JP, et al. Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors. Nature 2005; 436:103-107.
45. Pons S, Fattore L, Cossu G, Tolu S, Porcu E, McIntosh JM, et al. Crucial role of alpha4 and alpha6 nicotinic acetylcholine receptor subunits from ventral segmental area in systemic nicotine self-administration. J Neurosci 2008; 28:12318-12327.
46. Buisson B, Bertrand D. Nicotine addiction: the possible role of functional upregulation. Trends Pharmacol Sci 2002; 23:130-136.
47. 86Rb+ efflux in cortex and thalamus and alters relative expression of alpha 4 and beta 2 subunits. Mol Pharmacol 2008; 73:1796-1807.
48. Brown RW, Collins AC, Lindstrom JM, Whiteaker P. Nicotinic alpha5 subunit deletion locally reduces high-affinity agonist activation without altering nicotinic receptor numbers. J Neurochem 2007; 103:204-215.
49. Mao D, Perry DC, Yasuda RP, Wolfe BB, Kellar KJ. The alpha4beta2alpha5 nicotinic cholinergic receptor in rat brain is resistant to up-regulation by nicotine in vivo. J Neurochem 2008; 104:446-456.
50. McClure-Begley TD, King NM, Collins AC, Stitzel JA, Wehner JM, Butt CM. Acetylcholine-stimulated [3H]GABA release from mouse brain synaptosomes is modulated by alpha4beta2 and alpha4alpha5beta2 nicotinic receptor subtypes. Mol Pharmacol 2009; 75:918-926.
51. Salminen O, Murphy KL, McIntosh JM, Drago J, Marks MJ, Collins AC, et al. Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice. Mol Pharmacol 2004; 65:1526-1535.
52. Gahring LC, Persiyanov K, Dunn D, Weiss R, Meyer EL, Rogers SW. Mouse strain-specific nicotinic acetylcholine receptor expression by inhibitory interneurons and astrocytes in the dorsal hippocampus. J Comp Neurol 2004; 468:334-346.
53. Mague SD, Isiegas C, Huang P, Liu-Chen LY, Lerman C, Blendy JA. Mouse model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated behavior. Proc Natl Acad Sci 2009; 106:10847-10852.